Medigus Ltd. (NASDAQ:MDGS) Short Interest Down 81.1% in January
Medigus Ltd. (NASDAQ:MDGS) Short Interest Down 81.1% in January
Medigus Ltd. (NASDAQ:MDGS – Get Rating) saw a large decline in short interest in January. As of January 15th, there was short interest totalling 5,100 shares, a decline of 81.1% from the December 31st total of 27,000 shares. Based on an average daily volume of 33,600 shares, the days-to-cover ratio is presently 0.2 days. Currently, 0.9% of the shares of the company are short sold.
美迪格斯有限公司(纳斯达克:MDG-GET Rating)看到空头股数在1月份大幅下降。截至1月15日,空头股数共有5,100股,较12月31日的27,000股下降了81.1%。以日均成交量33,600股计算,目前天数与回补比率为0.2天。目前,该公司0.9%的股份被卖空。
Medigus Trading Down 3.9 %
Medigus股价下跌3.9%
Shares of MDGS stock traded down $0.20 during midday trading on Monday, reaching $4.87. 4,600 shares of the company traded hands, compared to its average volume of 12,211. The firm's 50 day simple moving average is $5.89 and its two-hundred day simple moving average is $7.62. Medigus has a 1-year low of $4.45 and a 1-year high of $19.50. The company has a debt-to-equity ratio of 0.11, a current ratio of 1.39 and a quick ratio of 1.33.
在周一午盘交易中,千年发展目标的股票交易价格下跌0.2美元,至4.87美元。该公司4600股易手,而其平均成交量为12,211股。该公司的50日简单移动均线切入位为5.89美元,200日简单移动均线切入位为7.62美元。Medigus的一年低点为4.45美元,一年高位为19.50美元。该公司的债务权益比为0.11,流动比率为1.39,速动比率为1.33。
Medigus Dividend Announcement
迈迪格斯股息公告
The business also recently declared a dividend, which was paid on Wednesday, December 28th. Stockholders of record on Tuesday, December 20th were given a dividend of $0.85 per share. The ex-dividend date was Monday, December 19th. This represents a dividend yield of 12.9%.
该公司最近还宣布了股息,股息于12月28日(星期三)支付。12月20日(星期二)登记在册的股东获得了每股0.85美元的股息。除息日期是12月19日星期一。这意味着股息收益率为12.9%。
Institutional Investors Weigh In On Medigus
机构投资者买入Medigus股票
About Medigus
关于梅迪格斯
(Get Rating)
(获取评级)
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities.
迈迪格斯有限公司是一家以技术为基础的公司,在美国、欧洲、中国、以色列和国际上提供与医疗相关的设备和产品。它提供Medigus超声外科吻合器,这是一种用于治疗胃食道反流性疾病的内窥镜系统。该公司还开发了生物凝胶,以保护患者免受生物威胁,并减少过敏原和病毒通过上呼吸道和眼腔的入侵。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on Medigus (MDGS)
- 4 High-Yield Dividend Kings For 2023
- Will 2023 be a Good Year for Goodyear Tire Stock?
- Lululemon Stock, Buying Opportunity on Lowered Guidance?
- Is Delta On Track To Hit A Fresh 52-Week High?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 免费获取StockNews.com关于Medigus的研究报告(MDG)
- 2023年4大高收益股利之王
- 2023年对固特异轮胎库存来说会是一个好年份吗?
- Lululemon股票,买入机会对下调指引?
- 达美航空有望创下52周新高吗?
- 你应该把这些沃伦·巴菲特的股票加入你的投资组合吗?
Receive News & Ratings for Medigus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medigus and related companies with MarketBeat.com's FREE daily email newsletter.
接受Medigus Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Medigus和相关公司的最新新闻和分析师评级的每日简要摘要。